Discover Zealand Pharma's Q4 2024 earning highlights, key obesity pipeline advancements, and future plans for petrelintide and dapiglutide.

By keeping the metabolism continuously active, the Ice Water Hack ensures a steady energy supply throughout the day, preventing the typical mid-afternoon slump and eliminating mental fog. Many users ...

For the first time a semaglutide weight loss drug has been approved for use in Australia to also treat cardiovascular disease ...

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...

Aviv Joshua, MS, RDN, LDN, is a clinical dietitian with over ... that habit-based interventions helped people lose a significant amount of weight over 8-14 weeks. These interventions included ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

He suggests that rapid, clinically significant weight loss in people living with obesity can help improve many health conditions, including: obstructive sleep apnoea non-alcoholic fatty liver ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

While some muscle mass depletion is inevitable with all weight loss, there are concerns that the decline is much more significant when ... the need for clinical evidence of health benefits beyond ...